Evolent Health Q4 Top-Line Beats Expectation, Analyst Points To Visible Growth Outlook
Evolent Health Inc (NYSE:EVH) reported Q4 adjusted EPS of $0.10, missing the consensus of $0.16, compared to $0.08 a year…
RBC Capital Reiterates Outperform on Evolent Health, Maintains $44 Price Target
RBC Capital analyst Sean Dodge reiterates Evolent Health (NYSE:EVH) with a Outperform and maintains $44 price target.
Evolent Health Q4 Adj. EPS $0.10 Misses $0.16 Estimate, Sales $382.43M Beat $372.93M Estimate
Evolent Health (NYSE:EVH) reported quarterly earnings of $0.10 per share which missed the analyst consensus estimate of $0.16 by 37.5 percent. This is a 25 percent increase over earnings of $0.08 per share from the same
Earnings Scheduled For February 22, 2023
Companies Reporting Before The Bell
• Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022.
Foot Locker, Ross Stores, Palo Alto Networks, And Other Big Gainers From Friday
U.S. stocks closed higher on Friday, with the Dow Jones gaining around 200 points. Here is the list of some big stocks recording gains in the previous session.
This Analyst Is Bullish On Evolent Health’s Recent Deal, Calls ‘Highly Strategic Acquisition’
Thursday after close, Evolent Health Inc (NYSE:EVH) agreed to acquire Magellan Specialty Health, the specialty benefit management organization owned by Centene…
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday’s Mid-Day Session
Gainers
PaxMedica, Inc. (NASDAQ: PXMD) gained 53.5% to $2.38 after the company announced an equity investment agreement for up to $20 million with Lincoln Park Capital.
Cowen & Co. Maintains Outperform on Evolent Health, Raises Price Target to $57
Cowen & Co. analyst Charles Ryhee maintains Evolent Health (NYSE:EVH) with a Outperform and raises the price target from $52 to $57.
Centene Agrees To Divest Magellan Specialty Health To Evolent Health
Evolent Health Inc (NYSE:EVH) has agreed to acquire NIA (also known as Magellan Specialty Health), the specialty benefit management organization owned by Centene…